Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002090172-26-000002
Filing Date
2026-03-02
Accepted
2026-03-02 16:22:37
Documents
1
Period of Report
2026-02-26

Document Format Files

Seq Description Document Type Size
1 form4-03022026_090334.html 4  
1 form4-03022026_090334.xml 4 4092
  Complete submission text file 0002090172-26-000002.txt   5644
Mailing Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087
Business Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVALO THERAPEUTICS, INC. 1500 LIBERTY RIDGE DRIVE, SUITE 321 WAYNE PA 19087
Business Address
Boyd Taylor (Reporting) CIK: 0002090172 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 26708022